Astellas notches another protein degrader pact with $21M upfront for PeptiDream

Astellas notches another protein degrader pact with $21M upfront for PeptiDream

Source: 
Fierce Biotech
snippet: 

Is there anything Astellas likes more than a protein degrader pact? The Japanese pharma has followed up agreements with the likes of Cullgen and Generian Pharmaceuticals by tapping PeptiDream for its latest partnership.